| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy
|
Kinali, Maria
|
|
2002
|
12 |
S |
p. S169-S174
6 p.
|
article
|
| 2 |
A web-accessible complete transcriptome of normal human and DMD muscle
|
Bakay, Marina
|
|
2002
|
12 |
S |
p. S125-S141
17 p.
|
article
|
| 3 |
CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci
|
Kapsa, R.M.I
|
|
2002
|
12 |
S |
p. S61-S66
6 p.
|
article
|
| 4 |
Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG)
|
Escolar, Diana M
|
|
2002
|
12 |
S |
p. S147-S154
8 p.
|
article
|
| 5 |
Considerations to the policy of future clinical therapeutic trials in DMD
|
Reitter, Bernd
|
|
2002
|
12 |
S |
p. S166-S168
3 p.
|
article
|
| 6 |
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies
|
Thioudellet, Christine
|
|
2002
|
12 |
S |
p. S49-S51
3 p.
|
article
|
| 7 |
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies
|
Fardeau, Michel
|
|
2002
|
12 |
S |
p. S52-S54
3 p.
|
article
|
| 8 |
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies
|
Romero, Norma Beatriz
|
|
2002
|
12 |
S |
p. S45-S48
4 p.
|
article
|
| 9 |
Dystrobrevin dynamics in muscle–cell signalling: a possible target for therapeutic intervention in Duchenne muscular dystrophy?
|
Blake, Derek J
|
|
2002
|
12 |
S |
p. S110-S117
8 p.
|
article
|
| 10 |
Dystrophin and functionally related proteins in the nematode Caenorhabditis elegans
|
Ségalat, Laurent
|
|
2002
|
12 |
S |
p. S105-S109
5 p.
|
article
|
| 11 |
Editorial Board
|
|
|
2002
|
12 |
S |
p. ii-
1 p.
|
article
|
| 12 |
Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice
|
Boer, Judith M.
|
|
2002
|
12 |
S |
p. S118-S124
7 p.
|
article
|
| 13 |
Foreword
|
|
|
2002
|
12 |
S |
p. S1-S2
2 p.
|
article
|
| 14 |
Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?
|
Wells, Dominic J
|
|
2002
|
12 |
S |
p. S11-S22
12 p.
|
article
|
| 15 |
Glucocorticoid-mediated regulation of utrophin levels in human muscle fibers
|
Courdier-Fruh, Isabelle
|
|
2002
|
12 |
S |
p. S95-S104
10 p.
|
article
|
| 16 |
Multivariate evaluation of the functional recovery obtained by the overexpression of utrophin in skeletal muscles of the mdx mouse
|
Gillis, Jean-Marie
|
|
2002
|
12 |
S |
p. S90-S94
5 p.
|
article
|
| 17 |
Myoblast transplantation
|
Partridge, Terry
|
|
2002
|
12 |
S |
p. S3-S6
4 p.
|
article
|
| 18 |
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy?
|
Ferrari, Giuliana
|
|
2002
|
12 |
S |
p. S7-S10
4 p.
|
article
|
| 19 |
Oligonucleotide-mediated gene therapy for muscular dystrophies
|
Rando, Thomas A
|
|
2002
|
12 |
S |
p. S55-S60
6 p.
|
article
|
| 20 |
Pharmacological control of cellular calcium handling in dystrophic skeletal muscle
|
Ruegg, Urs T
|
|
2002
|
12 |
S |
p. S155-S161
7 p.
|
article
|
| 21 |
Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness
|
De Luca, Annamaria
|
|
2002
|
12 |
S |
p. S142-S146
5 p.
|
article
|
| 22 |
Recombinant micro-genes and dystrophin viral vectors
|
Dickson, G
|
|
2002
|
12 |
S |
p. S40-S44
5 p.
|
article
|
| 23 |
Screening for antisense modulation of dystrophin pre-mRNA splicing
|
Dickson, G
|
|
2002
|
12 |
S |
p. S67-S70
4 p.
|
article
|
| 24 |
Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research
|
Muntoni, Francesco
|
|
2002
|
12 |
S |
p. S162-S165
4 p.
|
article
|
| 25 |
Strategies for muscle-specific targeting of adenoviral gene transfer vectors
|
Thirion, Christian
|
|
2002
|
12 |
S |
p. S30-S39
10 p.
|
article
|
| 26 |
Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
|
Aartsma-Rus, Annemieke
|
|
2002
|
12 |
S |
p. S71-S77
7 p.
|
article
|
| 27 |
The role of utrophin in the potential therapy of Duchenne muscular dystrophy
|
Perkins, Kelly J
|
|
2002
|
12 |
S |
p. S78-S89
12 p.
|
article
|
| 28 |
Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin
|
Scott, Jeannine M
|
|
2002
|
12 |
S |
p. S23-S29
7 p.
|
article
|
Journal description